Floor, Silom Road, Suriyawong, Bangrak, Bangkok 10500, Thailand. Tel. 02-634-0225 Fax 02-634-0135 www.interpharma.co.th 3-Month Period Ending March 31st 2020 2019 Change MB % MB % MB % Cost of Sales 35.76
operating expenses in Q1–2021 increased from Q1–2020 and decreased from Q4–2020 at a similar rate with an increase or decrease in revenue each quarter, mainly due to the change rate in the cost that increases
service income and the trading income which was recognized for the first time in year 2018. 9 Months 9 Months 2018 2017 Change % Change Revenue 1,233.10 1,111.90 121.20 11% Cost 1,117.51 941.45 Gross profit
derived from the management service income and the trading income which was recognized for the first time in year 2018. 2018 2017 Change % Change Revenue 1,672.58 1,580.25 92.32 6% Cost 1,509.05 1,335.73
input cost to the price of the products. Anyway, the economic recession threatens to the price structure that the company can not specify the price change with the corresponding changes of cost
can not specify the price change with the corresponding changes of cost. Consequently, it affected the profit margin. The Company still has no policy to overstock but to manage the inventory turnover
economic recession threatens to the price structure that the Company can not specify the price change with the corresponding changes of cost. Consequently, it affected the profit margin. The Company still
service 858.3 828.9 819.3 818.2 (1.1) (0.1) 3,324.7 3,415.7 (91.0) (2.7) Change YoY Change QoQ 2019 2018Q1-2019Cost of sales and services Q2-2019 Q3-2019 Q4-2019 From the table above, cost of sales and